Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease

被引：0
|
作者：
Paniz Vafaei
Sahar Naderi
Andrew P. Ambrosy
Justin J. Slade
机构：
[1] Kaiser Permanente San Francisco Medical Center,Department of Cardiology
[2] Kaiser Permanente Northern California,Division of Research
来源：
Current Atherosclerosis Reports | 2021年 / 23卷
关键词：
Stable ischemic heart disease; Coronary artery disease; Optimal medical therapy; Percutaneous coronary intervention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PATIENTS AT HIGH-RISK FOR ISCHEMIC COMPLICATIONS
    LINCOFF, AM
    JOURNAL OF INVASIVE CARDIOLOGY, 1994, 6 : A13 - A18
  • [32] Effect of maximum dose of atorvastatin on inflammation, thrombogenesis and fibrinolysis in high-risk patients with ischemic heart disease
    Tello, A
    Marín, F
    Roldán, V
    García-Herola, A
    Lorenzo, S
    Climent, VE
    de Teresa, L
    Sogorb, F
    REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (08): : 934 - 940
  • [33] PHARMACOLOGICAL RESPONSE TO LOW-DOSE WARFARIN IN PATIENTS AT HIGH-RISK OF ISCHEMIC HEART-DISEASE
    MEADE, TW
    PARK, BK
    STIRLING, Y
    WILKES, H
    WINN, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (01) : P146 - P146
  • [34] PROLONGED TREATMENT WITH OBZIDANE OF ISCHEMIC-HEART-DISEASE PATIENTS WITH HIGH-RISK OF SUDDEN-DEATH
    OSTROVSKAYA, TP
    MAZUR, NA
    DOKUCHAEVA, EA
    SMIRNOVA, TM
    IVANOVA, LA
    SUMAROKOV, AB
    KULGINSKAYA, IV
    SVET, EA
    KOTLYAROV, VV
    ILYUSHINA, IP
    KARDIOLOGIYA, 1981, 21 (03) : 105 - 105
  • [35] FAMILIAL CANCER - IMPLICATIONS FOR SURGICAL MANAGEMENT OF HIGH-RISK PATIENTS
    LYNCH, HT
    ORGAN, CH
    HARRIS, RE
    GUIRGIS, HA
    LYNCH, PM
    LYNCH, JF
    SURGERY, 1978, 83 (01) : 104 - 113
  • [36] The relevance of recognizing diabetes mellitus as high-risk category for ischemic heart disease
    Boskovic, M.
    Venecanin, M.
    Joksimovic, Polovina L.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 101S - 101S
  • [37] High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis
    Faurschou, Mikkel
    Mellemkjaer, Lene
    Starklint, Henrik
    Kamper, Anne-Lise
    Tarp, Ulrik
    Voss, Anne
    Jacobsen, Soren
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (11) : 2400 - 2405
  • [38] Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres, Kathleen A.
    Desai, Karan P.
    Sidhu, Mandeep S.
    Maron, David J.
    Boden, William E.
    FUTURE CARDIOLOGY, 2016, 12 (01) : 35 - 44
  • [39] Statins for high-risk patients without heart disease or high cholesterol
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1225): : 1 - 3
  • [40] Genetic score based on high-risk genetic polymorphisms and early onset of ischemic heart disease in an Italian cohort of ischemic patients
    Andreassi, M. G.
    Adlerstein, D.
    Vecoli, C.
    Shehi, E.
    Fantinato, S.
    Sampietro, T.
    Coceani, M.
    Neglia, D.
    L'abbate, A.
    Carpeggiani, C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 536 - 536
12345